𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cisplatin-Based Chemotherapy in the Management of Germ Cell Tumors of the Ovary: The Institut Gustave Roussy Experience

✍ Scribed by Stéphane Culine; Catherine Lhomme; Joseph Kattan; Guy Michel; Pierre Duvillard; Jean-Pierre Droz

Book ID
115617070
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
75 KB
Volume
64
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is there a role for second-look laparoto
Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy
✍ Culine, Stéphane; Lhomme, Catherine; Michel, Guy; Leclere, Jérome; Duvillard, Pi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB 👁 2 views

The last two decades have seen great improvements in the management of patients with germ-cell tumors of the ovary. The initial treatment approach includes conservative surgery and cisplatin-based chemotherapy in most cases. At completion of chemotherapy, the role of second-look surgery remains ques

Cisplatin and ifosfamide with either vin
Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients: The Institut Gustave Roussy experience
✍ Fadi Farhat; Stéphane Culine; Christine Théodore; Mohamed Békradda; Marie-Josée 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 476 KB 👁 2 views

## BACKGROUND. Approximately 30% of patients with metastatic germ cell tumors require salvage chemotherapy for recurrent or refractory disease after first-line treatment. The optimal salvage chemotherapy regimen remains to be determined. ## METHODS. Fifty-four patients with metastatic germ cell